The upregulated miR-326 was revealed to decrease SMO expression, resulting in an elevated rate of apoptosis in chronic myeloid leukemia (CML) cells, which could be beneficial in eradicating CD34+ CML stem cells [78]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.